The DrugAbacus is referenced in relation to frameworks that consider value in the price of cancer drugs.
OBR Oncology 06/07/2016
Value Tools at ASCO 2016: Building a Framework for Prime Time
Lynne Lederman reports on the 2016 American Society of Clinical Oncology (ASCO) Annual Meeting.
Lynne Lederman reports on the 2016 American Society of Clinical Oncology (ASCO) Annual Meeting on Collective Wisdom: The Future of Patient-Centered Care and Research discussion on value frameworks, as well as the results of a value survey conducted during and after ASCO by ZS in collaboration with WebMD that was completed by 93 medical or hematologic oncologists who practice in community or academic settings.